Rayan K AL Jurdi, MD

Co-Founder and Psychiatrist


- Received medical degree at the American University of Beirut, Beirut , Lebanon.
- Completed internship and residency at Baylor College of Medicine
- Completed a fellowship in psychosomatics at Baylor College of Medicine
- Board certified in Psychiatry by the American Board of Psychiatry and Neurology
- Board certified in Behavioral Neurology and Neuropsychiatry by the United Council for Neurologic Subspecialties
- Most recently served as the Deputy Executive, Mental Health Care Line and the Co-Director Network of Dedicated Enrollment Sites at the Michael E. DeBakey Veterans Affairs Medical Center
- More than thirteen years in academia serving as Associate Professor of Psychiatry at the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine
- Inducted into the Baylor College of Medicine Academy of Distinguished Educators
- Recipient of Outstanding Researcher of the Year Award from Michael E. DeBakey Veterans Affairs Medical Center


Dr. Rayan Al Jurdi has been a trailblazer in new forms of psychoneurological, neuropharmacological and neurological research. He has also been instrumental in bridging the gap between research initiatives and implementation in a patient setting. His work with ketamine treatment has helped bring the effective method beyond experiments into actual clinical use, helping patients find relief in novel ways.
Dr. Al Jurdi’s interests go beyond medicine into pushing state of the art patient care models, and his biggest desire is for he and his colleagues to have a more direct impact on patients’ care.
He has been involved in many research protocols and part of design teams of single-site research, multicenter and global research serving as principal or co-investigator on more than 35 research protocols. The funding sources for these research programs has been diverse, including the National Institute of Mental Health, the Department of Defense, foundations, industries and local support. His research focuses on the psychopharmacology of treatment resistant mood disorder, including the clinical use of ketamine, late life depression, bipolar disorder, genetics of mental illness and transcranial magnetic stimulation. Dr. Al Jurdi has been the recipient of multiple awards in clinical care, teaching and research.